KalVista Pharmaceuticals, Inc. Annual General and Administrative Expense in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2013 to 2023.
  • KalVista Pharmaceuticals, Inc. General and Administrative Expense for the quarter ending July 31, 2024 was $17.6M, a 79.9% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. General and Administrative Expense for the twelve months ending July 31, 2024 was $62.1M, a 92.5% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual General and Administrative Expense for 2023 was $54.3M, a 77.4% increase from 2022.
  • KalVista Pharmaceuticals, Inc. annual General and Administrative Expense for 2022 was $30.6M, a 15.7% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual General and Administrative Expense for 2021 was $26.4M, a 59% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $54.3M +$23.7M +77.4% May 1, 2023 Apr 30, 2024 10-K 2024-07-11
2022 $30.6M +$4.15M +15.7% May 1, 2022 Apr 30, 2023 10-K 2024-07-11
2021 $26.4M +$9.81M +59% May 1, 2021 Apr 30, 2022 10-K 2024-07-11
2020 $16.6M +$3.61M +27.7% May 1, 2020 Apr 30, 2021 10-K 2023-07-10
2019 $13M +$2.1M +19.2% May 1, 2019 Apr 30, 2020 10-K 2022-07-07
2018 $10.9M +$2.06M +23.3% May 1, 2018 Apr 30, 2019 10-K 2021-07-13
2017 $8.86M -$2.32M -20.7% May 1, 2017 Apr 30, 2018 10-K 2020-07-01
2016 $11.2M +$6.31M +130% May 1, 2016 Apr 30, 2017 10-K 2019-07-16
2015 $4.87M +$1.45M +42.6% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-30
2014 $3.41M +$2.01M +143% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
2013 $1.4M Jan 1, 2013 Dec 31, 2013 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.